Plasma Carboxymethyl-Lysine, an Advanced Glycation End Product, and All-Cause and Cardiovascular Disease Mortality in Older Community-Dwelling Adults

OBJECTIVES: To determine whether older adults with high plasma carboxymethyl-lysine (CML), an advanced glycation end product, are at higher risk of all-cause and cardiovascular disease (CVD) mortality. DESIGN: Prospective cohort study. SETTING: Population-based sample of adults aged 65 and older res...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Semba, Richard D., Bandinelli, Stefania, Sun, Kai, Guralnik, Jack M., Ferrucci, Luigi
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2785105/
https://ncbi.nlm.nih.gov/pubmed/19682127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1532-5415.2009.02438.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires